R. Kanesvaran Et Al. , "Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)," European-Society-for-Medical-Oncology (ESMO) Asia Congress , vol.30, Singapore, Singapore, 2019
Kanesvaran, R. Et Al. 2019. Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE). European-Society-for-Medical-Oncology (ESMO) Asia Congress , (Singapore, Singapore).
Kanesvaran, R., Biswas, B., Danchaivijitr, P., Lim, C. S., Karabulut, B., Wong, Y. F., ... Coskun, H. S.(2019). Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE) . European-Society-for-Medical-Oncology (ESMO) Asia Congress, Singapore, Singapore
Kanesvaran, R. Et Al. "Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)," European-Society-for-Medical-Oncology (ESMO) Asia Congress, Singapore, Singapore, 2019
Kanesvaran, R. Et Al. "Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)." European-Society-for-Medical-Oncology (ESMO) Asia Congress , Singapore, Singapore, 2019
Kanesvaran, R. Et Al. (2019) . "Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)." European-Society-for-Medical-Oncology (ESMO) Asia Congress , Singapore, Singapore.
@conferencepaper{conferencepaper, author={R. Kanesvaran Et Al. }, title={Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)}, congress name={European-Society-for-Medical-Oncology (ESMO) Asia Congress}, city={Singapore}, country={Singapore}, year={2019}}